Skip to content

13F-HR filed by Endurant Capital Management LP

Endurant Capital Management LP filed this 13F-HR for the quarter ended 2019-06-30, filed 2019-08-14, with 50 holding rows worth $253,641,000.

Accession
0001633055-19-000005
Filed
2019-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2019

A holdings report, 50 entries on the cover page, a total value of $253,641,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $253,641,000 with VALUE read as thousands by filing date, 13F file number 028-16634. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
TAKEDA PHARMACEUTICAL CO LTD SPONSORED ADS874060205ADR932,967$16,514,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW82,900$14,333,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock109,632$12,908,000thousands by filing date
WRIGHT MED GROUP N VN96617118ORD SHS371,979$11,092,000thousands by filing date
R1 RCM INC749397105COM830,809$10,452,000thousands by filing date
Cigna Corporation125523100COM61,590$9,704,000thousands by filing date
PRA HEALTH SCIENCES INC69354M108COM97,200$9,637,000thousands by filing date
INTRICON CORP46121H109COM389,795$9,106,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS629,236$8,658,000thousands by filing date
STANDARD BIOTOOLS INC34385PAA6NOTE 2.750% 2/08,756,000$8,386,000thousands by filing date
IRHYTHM HOLDINGS INC COM450056106Stock103,448$8,181,000thousands by filing date
SIENTRA INC82621J105COM1,285,855$7,921,000thousands by filing date
HUMANA INC COM444859102Stock27,797$7,375,000thousands by filing date
ENCOMPASS HEALTH CORP COM29261A100Stock114,801$7,274,000thousands by filing date
AVEDRO INC05355N109COM357,942$7,030,000thousands by filing date
ATRICURE INC04963C209COM219,038$6,536,000thousands by filing date
VOCERA COMMUNICATIONS INC92857F107COMMON STOCK203,000$6,480,000thousands by filing date
AbbVie,Inc.00287Y109COM89,008$6,473,000thousands by filing date
CENCORA INC COM03073E105Stock73,503$6,267,000thousands by filing date
INTERSECT ENT INC46071F103COM270,561$6,158,000thousands by filing date
HCA Healthcare Inc40412C101COM43,623$5,897,000thousands by filing date
SANOFI SA SPONSORED ADR80105N105ADR120,614$5,219,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR124,859$5,154,000thousands by filing date
EVOLENT HEALTH INC30050BAB7NOTE 2.000%12/05,596,000$4,974,000thousands by filing date
DENTSPLY SIRONA INC24906P109COM82,813$4,833,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM173,238$4,248,000thousands by filing date
NEVRO CORP64157F103COM63,394$4,110,000thousands by filing date
Bristol-Myers Squibb Company110122108COM86,297$3,914,000thousands by filing date
LIQUIDIA CORPORATION COM NEW53635D202Stock468,981$3,752,000thousands by filing date
ACLARIS THERAPEUTICS INC COM00461U105Stock1,629,327$3,568,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS18,210$3,139,000thousands by filing date
INTEGRA LIFESCIENCES HLDGS C457985208COM NEW42,827$2,392,000thousands by filing date
SURGERY PARTNERS INC86881A100COM287,720$2,342,000thousands by filing date
NEON THERAPEUTICS INC64050Y100COM465,650$2,207,000thousands by filing date
RVL PHARMACEUTICALS PLCG6S41R101COM514,239$1,954,000thousands by filing date
DAVITA INC COM23918K108Stock32,566$1,832,000thousands by filing date
GRITSTONE BIO INC39868T105COM143,752$1,601,000thousands by filing date
SENSEONICS HLDGS INC81727UAA3NOTE 5.250% 2/01,500,000$1,540,000thousands by filing date
MARINUS PHARMACEUTICALS INC56854Q101COM362,189$1,503,000thousands by filing date
SI BONE INC825704109COM65,216$1,326,000thousands by filing date
TANDEM DIABETES CARE INC875372203COM NEW19,579$1,263,000thousands by filing date
BIO RAD LABS INC090572207CL A3,735$1,168,000thousands by filing date
GENOCEA BIOSCIENCES INC372427401COMMON STOCK289,714$1,136,000thousands by filing date
PEDIATRIX MEDICAL GROUP INC58502B106COM39,401$994,000thousands by filing date
ACTINIUM PHARMACEUTICALS INC00507W107COM2,481,355$610,000thousands by filing date
SAREPTA THERAPEUTICS INC803607100COM3,753$570,000thousands by filing date
ALIGN TECHNOLOGY INC COM016255101Stock1,962$537,000thousands by filing date
GLYCOMIMETICS INC38000Q102COM42,271$504,000thousands by filing date
TRANSLATE BIO INC.89374L104Common Stock38,772$490,000thousands by filing date
Adverum Biotechnologies, Inc.00773U108Common Stock31,869$379,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001633055-19-000005this filing2019-08-14acceptance time not in the bulk data set